OrbiMed Genesis GP LLC: insider buys
Every open-market stock purchase reported by OrbiMed Genesis GP LLC to the SEC on Form 4.
Total bought$63.57M
Purchases3
Companies3
Last purchase filedSep 30, 2026
Return on these buys-5.5%
OrbiMed Genesis GP LLC has made 3 open-market purchases worth $63.57M in 3 companies since Apr 23, 2026, according to SEC Form 4 filings. The most recent was filed on Sep 30, 2026: 950,000 shares of ADRX at $17.00 (Director, 10% Owner), worth $16.15M. The largest was $34.92M of BRVE on Aug 7, 2026. Taken together, these purchases are down 6% at the latest closing prices (split-adjusted, weighted by amount).
Companies OrbiMed Genesis GP LLC bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| BRVE | Braveheart Bio, Inc. | Director, 10% Owner | 1 | $34.92M | — | Aug 11 |
| ADRX | ADARx Pharmaceuticals, Inc. | Director, 10% Owner | 1 | $16.15M | +0.0% | Sep 30 |
| PRLD | Prelude Therapeutics Inc | Director, 10% Owner | 1 | $12.50M | -13% | Apr 23 |
Get the next OrbiMed Genesis GP LLC purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30 | ADRXADARx Pharmaceuticals, Inc. | OrbiMed Genesis GP LLC +4Director, 10% Owner | $16.15M | 950,000 | $17.00 | +0.0% | — | Sep 28 | SEC |
| Aug 11 | BRVEBraveheart Bio, Inc. | OrbiMed Genesis GP LLC +2Director, 10% Owner | $34.92M | 1,940,000 | $18.00 | — | — | Aug 7 | SEC |
| Apr 23 | PRLDPrelude Therapeutics Inc | OrbiMed Genesis GP LLC +3Director, 10% Owner | $12.50M | 2,815,315 | $4.44 | -13% | — | Apr 21 | SEC |